See All Slides - tctmd.com

Slides

Presentation AHA 2023

Efficacy and safety of anticoagulation with edoxaban in patients with Atrial high rate-episodes (AHRE) durations ≥ 24 hours - The NOAH-AFNET 6 trial

Presenter: Nina Becher

November 14, 2023

Presentation AHA 2023

Dapagliflozin in myocardial infarction without diabetes or heart failure

Presenter: Stefan James

November 14, 2023

Presentation TCT 2023

TCT 392: Prognostic impact of vasopressor test during edge-to-edge repair of secondary mitral regurgitation

Presenter: Jose Carlos Gonzalez Gutiérrez

October 26, 2023

Presentation TCT 2023

TCT 749: Predictors of Suboptimal Stent Expansion Following Intravascular Lithotripsy for Coronary In-Stent Restenosis: Insights from Intravascular Imaging

Presenter: Keisuke Yasumura

October 24, 2023

Presentation TCT 2023

TCT 261: Review of Short-term Outcomes of ACURATE neo2

Presenter: Akihiro Tobe

October 26, 2023

Presentation TCT 2023

TCT 340: Sex Differences in Patients with Three-vessel Coronary Artery Disease Undergoing FFR-guided PCI or CABG: A Pre-specified Analysis of the FAME 3 Trial

Presenter: Kuniaki Takahashi

October 26, 2023

Presentation TCT 2023

TCT 436: Outcomes of Renin-Angiotensin Inhibitors following Transcatheter Aortic Valve Implantation

Presenter: Rahul Gupta

October 26, 2023

Presentation TCT 2023

TCT 378: A novel miRNA nanocarrier for local device-based pharmacotherapy

Presenter: Stephanie Bettink

October 26, 2023

Presentation TCT 2023

TCT 206: Prediction of the Individual Rate of Progression of Aortic Stenosis and its Association with Clinical Outcomes

Presenter: Constantijn Venema

October 26, 2023

Presentation TCT 2023

TCT 775: A Machine Learning Based Model Predicts Death in Patients with Severe Asymptomatic Aortic Stenosis

Presenter: APURVA BHARUCHA

October 26, 2023

Advertisement

Slides

Efficacy and safety of anticoagulation with edoxaban in patients with Atrial high rate-episodes (AHRE) durations ≥ 24 hours - The NOAH-AFNET 6 trial

Dapagliflozin in myocardial infarction without diabetes or heart failure

TCT 392: Prognostic impact of vasopressor test during edge-to-edge repair of secondary mitral regurgitation

TCT 749: Predictors of Suboptimal Stent Expansion Following Intravascular Lithotripsy for Coronary In-Stent Restenosis: Insights from Intravascular Imaging

TCT 261: Review of Short-term Outcomes of ACURATE neo2

TCT 340: Sex Differences in Patients with Three-vessel Coronary Artery Disease Undergoing FFR-guided PCI or CABG: A Pre-specified Analysis of the FAME 3 Trial

TCT 436: Outcomes of Renin-Angiotensin Inhibitors following Transcatheter Aortic Valve Implantation

TCT 378: A novel miRNA nanocarrier for local device-based pharmacotherapy

TCT 206: Prediction of the Individual Rate of Progression of Aortic Stenosis and its Association with Clinical Outcomes

TCT 775: A Machine Learning Based Model Predicts Death in Patients with Severe Asymptomatic Aortic Stenosis

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content